Evidence map›Paper›PMID 21493872›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2011

Decision tree-based modeling of androgen pathway genes and prostate cancer risk.

Jill S Barnholtz-Sloan, Xiaowei Guan, Charnita Zeigler-Johnson, Neal J Meropol, Timothy R Rebbeck

Open access · bronzeAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Human Orphan Cytochromes P450: An Update.Current drug metabolism · 2022
    Article
  4. Article
  5. Frontiers in physiology · 2017
    Article
  6. Article
  7. Genetic variation in CYP3A43 is associated with response to antipsychotic medication.Journal of neural transmission (Vienna, Austria : 1996) · 2015
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Jill S Barnholtz-SloanCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106-5065, USA. jsb42@case.edu
Xiaowei Guan
Charnita Zeigler-Johnson
Neal J Meropol
Timothy R Rebbeck
University Hospitals Case Medical Center · USUniversity of Pennsylvania · USCase Western Reserve University · US

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARK R CHANCE · 1987 to 2026
$142.3M
Segregation and Racial Disparities in Prostate CancerP50CA105641 · NCI · UNIVERSITY OF PENNSYLVANIA · PI REBBECK, TIMOTHY R · 2003 to 2009
$9.6M
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCERR01CA085074 · NCI · UNIVERSITY OF PENNSYLVANIA · PI REBBECK, TIMOTHY R · 1999 to 2010
$2.9M
NCI NIH HHS P01-CA105641NCI NIH HHS P30 CA043703NCI NIH HHS P30-CA043703NCI NIH HHS P50 CA105641NCI NIH HHS R01 CA085074NCI NIH HHS R01-CA08574
6 · The paper itself

Abstract

backgroundInherited variability in genes that influence androgen metabolism has been associated with risk of prostate cancer. The objective of this analysis was to evaluate interactions for prostate cancer risk by using classification and regression tree (CART) models (i.e., decision trees), and to evaluate whether these interactive effects add information about prostate cancer risk prediction beyond that of "traditional" risk factors.

methodsWe compared CART models with traditional logistic regression (LR) models for associations of factors with prostate cancer risk using 1,084 prostate cancer cases and 941 controls. All analyses were stratified by race. We used unconditional LR to complement and compare with the race-stratified CART results using the area under curve (AUC) for the receiver operating characteristic curves.

resultsThe CART modeling of prostate cancer risk showed different interaction profiles by race. For European Americans, interactions among CYP3A43 genotype, history of benign prostate hypertrophy, family history of prostate cancer, and age at consent revealed a distinct hierarchy of gene-environment and gene-gene interactions, whereas for African Americans, interactions among family history of prostate cancer, individual proportion of European ancestry, number of GGC androgen receptor repeats, and CYP3A4/CYP3A5 haplotype revealed distinct interaction effects from those found in European Americans. For European Americans, the CART model had the highest AUC whereas for African Americans, the LR model with the CART discovered factors had the largest AUC. CONCLUSION AND IMPACT: These results provide new insight into underlying prostate cancer biology for European Americans and African Americans.

Indexed as

Decision Support TechniquesDecision Trees3-Oxo-5-alpha-Steroid 4-DehydrogenaseAdultAgedAryl Hydrocarbon HydroxylasesCase-Control StudiesCytochrome P-450 CYP3ADNAHaplotypesHumansMaleMembrane ProteinsMiddle AgedNeoplasm StagingPolymerase Chain Reaction3-Oxo-5-alpha-Steroid 4-DehydrogenaseAR protein, humanAryl Hydrocarbon HydroxylasesCYP3A43 protein, humanCYP3A4 protein, humanCYP3A5 protein, humanCytochrome P-450 CYP3ADNAMembrane ProteinsReceptors, AndrogenSRD5A2 protein, human

Identifiers

PMID21493872
PMCPMC3111844
OpenAlexW2151240681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.